Pharmacogenomics Education Program
Pharmacogenomics Education Program 
Description: The “Pharmacogenomics Education Program: Bridging the Gap between Science and Practice” (PharmGenEd) is an evidence-based pharmacogenomics education program designed for pharmacists and physicians, pharmacy and medical students, and other healthcare professionals. The program team at UCSD Skaggs School of Pharmacy and Pharmaceutical Sciences is collaborating with national pharmacy and medical associations to bring pharmacogenomics educational materials to more than 100,000 pharmacists, students, and Healthcare Professionals.
The program core members are UCSD faculty members: Grace M. Kuo, PharmD, MPH (Principal Investigator/Program Director); Kelly C. Lee, PharmD, BCPP; Joseph D. Ma, PharmD; James R. Halpert; PhD, Philip E. Bourne, PhD; Theodore Ganiats, MD; and Palmer W. Taylor, PhD. Consultants include Karen S. Hudmon, DrPH, MS, RPh (Purdue University) and Magnus Ingelman-Sundberg, PhD (Karolinska Institute in Sweden).
We welcome healthcare professionals, academicians, and researchers to join this virtual community. We also welcome you to visit our program website (link provided below).
Acknowledgment: This project is funded by the CDC Grant No. IU38GD00070 from 2008 to 2011. The program contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC.
The program core members are UCSD faculty members: Grace M. Kuo, PharmD, MPH (Principal Investigator/Program Director); Kelly C. Lee, PharmD, BCPP; Joseph D. Ma, PharmD; James R. Halpert; PhD, Philip E. Bourne, PhD; Theodore Ganiats, MD; and Palmer W. Taylor, PhD. Consultants include Karen S. Hudmon, DrPH, MS, RPh (Purdue University) and Magnus Ingelman-Sundberg, PhD (Karolinska Institute in Sweden).
We welcome healthcare professionals, academicians, and researchers to join this virtual community. We also welcome you to visit our program website (link provided below).
Acknowledgment: This project is funded by the CDC Grant No. IU38GD00070 from 2008 to 2011. The program contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC.
Latest discussionscreate a topic | view all
No discussion topic has been created in this community.
Why don't you start a discussion?
Why don't you start a discussion?
Community Pubcastsview all
Age-related macular degeneration (AMD) is the most common cause of irreversible vision loss in the developed world and has a strong genetic predisposition. A locus at human chromosome 10q26 affects the risk of AMD, but the precise gene(s) have not been identified. We genotyped 581 AMD cases and...
Community Postercastsview all
Dr. Magnus Ingelman-Sundberg presents his recent paper on "Pharmacogenomic biomarkers for prediction of "severe adverse drug reactions" published in the New England Journal of Medicine on Feb 2008.
Community Videosview all
This webinar was presented on Thursday, August 26, 2010 by Dr. John M. Valgus. Dr. Valgus discusses select pharmacogenomic effects in patients with solid tumors.
This webinar was presented on Tuesday, August 24, 2010 by Dr. Jeffrey R. Bishop. Dr. Bishop discusses select pharmacogenomic effects in patients treated with antipsychotic medications.
This webinar was recorded on Wednesday, August 11, 2010 by Dr. Grace Kuo, Dr. Joseph Ma, and Dr. Kelly Lee discussing the translation of pharmacogenomics into practice, pharmacogenomic nomenclature, examples of the therapeutic area: infectious diseases as well as ethical, legal, social (ELSI) and...
